Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.
暂无分享,去创建一个
E. Braunwald | C. Cannon | C. Granger | S. Murphy | B. Scirica | H. Anderson | C. Gibson | D. Moliterno | L. Rabbani | C. Lambrew | J. Ferguson | F. Aguirre | S. Sapp | J. Booth | Christopher P. Cannon | C. Granger | Frank V. Aguirre | Michael C. Gibson | Vernon H. Anderson | LeRoy E. Rabbani | Joan E. Booth | James J. Ferguson
[1] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[2] Robert Parrish,et al. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.
[3] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.
[4] P. Shekelle,et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? , 2001, JAMA.
[5] E. Braunwald,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.
[6] R. Centor,et al. Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. , 2000, JAMA.
[7] J. W. Schaeffer,et al. ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.
[8] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[9] M. Makary,et al. Association of unstable angina guideline care with improved survival. , 2000, Archives of internal medicine.
[10] C. Cannon,et al. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry. , 1999, American heart journal.
[11] C. Cannon,et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. , 1999, The American journal of cardiology.
[12] L. Klein,et al. Clinical practice guidelines in unstable angina improve clinical outcomes by assuring early intensive medical treatment. , 1999, Journal of the American College of Cardiology.
[13] N. Powe,et al. The association between hospital volume and survival after acute myocardial infarction in elderly patients. , 1999, The New England journal of medicine.
[14] Harlan M. Krumholz,et al. Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? , 1999 .
[15] R. Califf,et al. Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial. , 1998, Journal of the American College of Cardiology.
[16] E. Antman,et al. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy , 1998 .
[17] H. Krumholz,et al. Trends in the quality of care for Medicare beneficiaries admitted to the hospital with unstable angina. , 1998, Journal of the American College of Cardiology.
[18] F. Harrell,et al. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .
[19] D Wybenga,et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.
[20] E. Braunwald,et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. , 1996 .
[21] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[22] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[23] R. Califf,et al. Scorecard Cardiovascular Medicine: Its Impact and Future Directions , 1994, Annals of Internal Medicine.
[24] G. Lamas,et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. , 1992, The New England journal of medicine.
[25] P. Théroux,et al. Aspirin, heparin, or both to treat acute unstable angina. , 1988, The New England journal of medicine.
[26] E. Shapiro,et al. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. , 1986, Circulation.
[27] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.